Prevalence and management of mental health comorbidities in a German cohort of patients with Ehlers-Danlos syndromes and a generalized hypermobility spectrum disorder
Open Access
- 3 February 2026
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 21 (1)
Abstract
Objective: The objective of this study was to examine mental health comorbidities and their management in individuals living in Germany with generalized symptomatic hypermobility, including Ehlers-Danlos Syndromes (EDS) and generalized hypermobility spectrum disorder (G-HSD). Methods: We conducted a descriptive cross-sectional study at the EDS outpatient service, University Hospital of Cologne, Germany. A standardized self-report form was sent to all adults who were diagnosed with hypermobile EDS (hEDS), classical EDS (cEDS), classical-like EDS (clEDS) or G-HSD from December 2021 until May 2023. Participants completed an ad-hoc standardized, pseudonymized paper-based self- report form developed ad hoc for this study as along with the following validated instruments: the PHQ-9 (Personal Health Questionnaire with 9 items) and DASS (Depression Anxiety Stress Scales) regarding depression, stress, and anxiety, and the corresponding modules of the PHQ-D (Personal Health Questionnaire, German version) regarding eating disorders and alcohol abuse. Results: A total of 132 participants were included, of whom 99 completed the questionnaire. Overall, 85% of respondents reported experiencing a moderate to severe mental burden due to EDS/G-HSD. Self-reported lifetime prevalence of mental health diagnoses was 58.6%, with depression, posttraumatic stress disorder (PTSD) and anxiety disorders being the most common ones. 27.3% indicated at least two mental health disorders. The prevalence of symptom severity scores above the clinical cut-off of depression was 60.2% (according to the PHQ-9) and that of anxiety disorders was 45.4% (according to the DASS). Despite 68.7% of participants having received psychotherapy, our findings suggest that mental health conditions were probably underdiagnosed and likely undertreated in our patients. Conclusion: This is the first study examining mental health comorbidities in patients with EDS/G-HSD living in Germany. It adds to the growing body of evidence indicating that mental health disorders, particularly depression and anxiety, are highly prevalent in EDS, regardless of the subtype. Our survey also provides increased prevalence data for PTSD and eating disorders as well as data on the use of psychotherapy and antidepressants in EDS/G-HSD. There is a critical need for improved diagnostic pathways and treatment strategies that prioritize a multidisciplinary biopsychosocial approach in the care of these patients.Keywords
Funding Information
- Universitätsklinikum Köln
This publication has 58 references indexed in Scilit:
- Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers‐Danlos syndrome: A retrospective cross‐sectional study from an Italian reference centerAmerican Journal of Medical Genetics Part A, 2023
- Utilization of the 2017 diagnostic criteria for hEDS by the Toronto GoodHope Ehlers–Danlos syndrome clinic: A retrospective reviewAmerican Journal of Medical Genetics Part A, 2019
- Use of prescription opioid and other drugs among a cohort of persons with Ehlers–Danlos syndrome: A retrospective studyAmerican Journal of Medical Genetics Part A, 2019
- The 2017 international classification of the Ehlers–Danlos syndromesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2017
- The Ehlers–Danlos syndromes, rare typesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2017
- Psychiatric and psychological aspects in the Ehlers–Danlos syndromesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2017
- A framework for the classification of joint hypermobility and related conditionsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2017
- Hypermobile Ehlers–Danlos syndrome (a.k.a. Ehlers–Danlos syndrome Type III and Ehlers–Danlos syndrome hypermobility type): Clinical description and natural historyAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2017
- Psychopathological manifestations of joint hypermobility and joint hypermobility syndrome/ Ehlers–Danlos syndrome, hypermobility type: The link between connective tissue and psychological distress revisedAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2015
- Ehlers–Danlos syndrome, hypermobility type: A characterization of the patients' lived experienceAmerican Journal of Medical Genetics Part A, 2013